Stockscreener 앱 받기
0.4103
2.56%
-0.0108
시장 영업 전:
.39
-0.0203
-4.95%
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
What Did We Find About Insider Trading At Harvard Bioscience Inc (NASDAQ: HBIO)? - Stocksregister
Harvard Bioscience appoints new board member By Investing.com - Investing.com South Africa
Harvard Bioscience Approves Incentive Plan Amendment - TipRanks
Harvard Bioscience Appoints John Duke to Board of Directors - The Manila Times
Harvard Bioscience Strengthens Board with Ex-Corning Life Sciences Leader John Duke, Names New Lead Director - Stock Titan
Little Excitement Around Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Revenues As Shares Take 26% Pounding - simplywall.st
Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark - Yahoo Finance
Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions - MSN
Harvard Bioscience (HBIO): Analyst Lowers Price Target, Maintains Rating | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Target Price Reduced Amid Market Challenges | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Target Price Reduced Amid Market Chall - GuruFocus
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovations - GuruFocus
Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast By Investing.com - Investing.com South Africa
Harvard Bioscience Announces First Quarter 2025 Financial Results - GlobeNewswire
Harvard Bioscience: Q1 Earnings Snapshot - MySA
Harvard Bioscience (HBIO) Reports Q1 2025 Highlights Amid Financ - GuruFocus
Harvard Bioscience Q1 2025 Earnings Call Transcript - MarketBeat
Transcript : Harvard Bioscience, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com
Harvard Bioscience earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
HBIO Reports Decline in Q1 Revenue Amid Market Challenges | HBIO Stock News - GuruFocus
Harvard Bioscience earnings matched, revenue topped estimates - Investing.com
Harvard Bioscience Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Harvard Bioscience, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HBIO) - Seeking Alpha
Harvard Bioscience Q1 2025 slides: Revenue decline and goodwill impairment weigh on results - Investing.com Canada
Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast - Investing.com
Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceed - GuruFocus
Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceeding Estimates; Faces Net Loss Due to Goodwill Impairment - GuruFocus
Harvard Bioscience Q1 Net Income USD -50.34 Million - marketscreener.com
Harvard Bioscience Announces First Quarter 2025 Financial Results | HBIO Stock News - GuruFocus
Harvard Bioscience : Q1 2025 Harvard Bioscience, Inc. Earnings Conference Call - marketscreener.com
Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Report Preview: W - GuruFocus
What Is Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Share Price Doing? - Yahoo Finance
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET | HBIO Stock News - GuruFocus
Harvard Bioscience, Inc. to Announce Q1 2025 Financial Results on May 12, 2025 - Nasdaq
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at - Bluefield Daily Telegraph
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET - GlobeNewswire
Harvard Bioscience Sets Date for Q1 2025 Financial Results: What Investors Should Watch - Stock Titan
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET - IT Business Net
Is Now An Opportune Moment To Examine Harvard Bioscience, Inc. (NASDAQ:HBIO)? - simplywall.st
1.19%
0.75%
자본화:
|
볼륨(24시간):